Publication | Closed Access

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer

Surgical OncologyBreast OncologyHigher LevelsShorter Survival TimesMedicinePathologyBreast CancerCancer TreatmentBreast SurgeryOncologyRadiation OncologyTumor MicroenvironmentCancer Growth